U.S. Semiconductors Stock News

NYSE:RJF
NYSE:RJFCapital Markets

Is Raymond James (RJF) Management Turnover Quietly Reshaping Its Long‑Term Wealth Strategy?

Raymond James said that Independent Contractor Division director Kirk Bell has been appointed president of the division, effective April 1, 2026, joining both the firm’s Senior Leadership and Private Client Group Executive Leadership teams after prior president Shannon Reid’s resignation. This leadership change comes as the firm balances softer capital markets activity with growth in asset management and private client revenues ahead of its upcoming fiscal Q2 2026 earnings release. Next,...
NYSE:ALSN
NYSE:ALSNMachinery

Allison Transmission Buyout Of Dana Unit Reshapes Growth And Valuation Profile

Allison Transmission Holdings (NYSE:ALSN) is acquiring Dana’s Off-Highway business, expanding its reach beyond on-highway applications. The deal adds exposure to off-highway markets such as construction, agriculture and mining, widening Allison’s addressable customer base. Investors now have new information to assess Allison’s mix of end markets, revenue sources and integration priorities. Allison Transmission Holdings, trading at $117.06, has seen its share price rise 18.3% year to date...
NYSE:WK
NYSE:WKSoftware

Did Workiva's (WK) New AI-Focused CFO Just Recast Its Governance and Compliance Investment Narrative?

Earlier this year, Workiva appointed Barbara Larson as executive vice president and chief financial officer, drawing on her prior finance leadership roles at Workday and VMware to help oversee its AI-enabled governance, risk, compliance and sustainability platform, which is guiding toward US$1.00 billion in revenue in 2026. Her emphasis on embedding AI more deeply into Workiva’s platform to respond to rising regulatory demands highlights how leadership decisions could shape the company’s...
NYSE:DAVA
NYSE:DAVAIT

Endava (NYSE:DAVA) Earnings Swing To Loss Challenges Bullish Profitability Narratives

Endava (NYSE:DAVA) has just turned in a mixed Q2 2026 scorecard, with revenue of £184.1 million, a basic EPS loss of £0.13 and net income loss of £6.9 million, set against a trailing twelve month picture that shows £743.9 million of revenue, a small EPS loss of £0.05 and a net income loss of £2.9 million. Over the past few quarters, revenue has moved from £195.6 million and EPS of £0.12 in Q2 2025 to £184.1 million and EPS of a £0.13 loss in Q2 2026, while quarterly net income shifted from a...
NYSE:AGX
NYSE:AGXConstruction

Broadcom And 2 More Power Grid Technology Stocks With Deep Backlogs

Global markets are wrestling with stubborn inflation risks, volatile energy prices, and shifting central bank expectations, which is pushing many investors to look more closely at real world infrastructure. The power grid sits at the heart of that topic, linking AI data centers, electrified transport, and everyday homes to reliable energy. Our Power Grid Technology Stocks screener filters for profitable companies that build and equip this backbone, focusing on those already earning money from...
NasdaqGS:SRRK
NasdaqGS:SRRKBiotechs

Why Scholar Rock Holding (SRRK) Is Up 16.2% After Apitegromab BLA Resubmission With FDA-Aligned Manufacturing

On 31 March 2026, Scholar Rock announced it had resubmitted its Biologics License Application to the FDA for apitegromab in spinal muscular atrophy, now incorporating both the Catalent Indiana site and a second U.S.-based fill-finish facility in line with recent regulatory guidance. The resubmission, coming after an earlier Complete Response Letter that cited only third-party manufacturing observations, highlights how Scholar Rock has worked with Novo Nordisk’s Catalent unit and the FDA to...
NYSE:KTB
NYSE:KTBLuxury

Heritage Fashion Collaborations With J.Crew and Dr. Scholl’s Might Change The Case For Investing In Kontoor Brands (KTB)

In March 2026, Dr. Scholl’s Shoes announced a limited-edition collaboration with Kontoor Brands’ Wrangler, and J.Crew introduced an exclusive Lee x J.Crew capsule, both featuring Americana-inspired footwear, denim, and apparel across multiple categories and price points. These collaborations highlight how Kontoor is using heritage partnerships and fashion-forward capsules to broaden its reach, refresh brand perception, and tap into new style-minded consumer groups. Next, we’ll examine how...
NYSE:DX
NYSE:DXMortgage REITs

Is It Time To Reassess Dynex Capital (DX) After Recent Share Price Swings?

If you are wondering whether Dynex Capital is priced attractively at around US$12.76, it helps to separate short term share price swings from what the underlying value might suggest. The stock has recently shown mixed returns, with a 2.4% gain over the last 7 days, a 9.1% decline over 30 days, and year to date and 1 year returns of 9.4% decline and 15.2% respectively, while the 3 year and 5 year returns sit at 60.2% and 23.8%. Recent coverage has focused on how income focused investors view...
NYSE:NXDT
NYSE:NXDTREITs

NexPoint Diversified Real Estate Trust (NXDT) Q4 FFO Rebound Tests Bearish Narratives

NexPoint Diversified Real Estate Trust (NXDT) has wrapped up FY 2025 with fourth quarter total revenue of US$19.1 million, basic EPS of a US$0.75 loss, and funds from operations of US$86.1 million. This rounds out a trailing 12 month revenue line of US$86.0 million and a net loss of US$130.2 million. Over recent quarters, revenue has moved from US$28.7 million in Q1 2025 to US$21.2 million in Q2, US$16.9 million in Q3, and US$19.1 million in Q4. Quarterly basic EPS has ranged from a US$0.99...
NasdaqGS:OKTA
NasdaqGS:OKTAIT

Okta (OKTA) Valuation Check After Geopolitical Relief Rally And Mixed Shareholder Returns

Geopolitics, market relief and Okta’s recent move Okta (OKTA) gained 2.7% after reports that the U.S. may be willing to end its military campaign against Iran, easing fears around extended geopolitical tension and energy price shocks for equity markets. See our latest analysis for Okta. Beyond today’s relief rally, Okta’s recent moves have been mixed, with a 1 month share price return of 8.57% contrasting with a 1 year total shareholder return decline of 24.82%. Short term momentum is...
NasdaqGS:ATRO
NasdaqGS:ATROAerospace & Defense

Is It Time To Reassess Astronics (ATRO) After A 17% Monthly Pullback?

Wondering if Astronics at US$66.73 is priced for perfection or still offers value? This article breaks down what the current share price might be implying. The stock has seen a 1.7% decline over the past week and a 17.2% decline over the past month, yet it is still up 17.9% year to date and 169.8% over the last year, with a very large return over three years and a 262.1% return over five years. Recent coverage has focused on Astronics as an aerospace and defense supplier, including attention...
NasdaqGS:CINF
NasdaqGS:CINFInsurance

Cincinnati Financial’s 65 Year Dividend Record Meets Valuation And Earnings Test

Cincinnati Financial (NasdaqGS:CINF) has extended its dividend growth streak to 65 consecutive years. The company continues to emphasize disciplined underwriting and careful risk selection across its insurance portfolio. Management highlights investment discipline as a key support for its long running dividend track record. Cincinnati Financial focuses on property and casualty insurance, an area that regularly faces weather events and other large loss scenarios. In this context, a 65 year...
NYSE:AGBK
NYSE:AGBKBanks

Assessing AGI (AGBK) Valuation After Recent Share Price Weakness

AGI stock snapshot after recent performance shifts AGI (AGBK) has drawn attention after recent share price moves, with a 1 day gain of 1.1% contrasting with declines of 11.7% over the past week and 37.9% over the past month. See our latest analysis for AGI. The recent 1 day share price return of 1.1% sits against a weaker backdrop. The 30 day share price return of 37.9% and year to date share price return of 32.4% indicate fading momentum from earlier levels at the current share price of...
NasdaqGS:ZBIO
NasdaqGS:ZBIOBiotechs

Zenas BioPharma (ZBIO): Does This $300 Million Raise Clarify or Complicate Its Funding Strategy?

In late March 2026, Zenas BioPharma completed a US$100,000,000 follow-on equity offering at US$20 per share and a US$200,000,000 issue of 2.50% senior unsecured convertible notes due April 1, 2032. This combined US$300,000,000 capital raise meaningfully reshapes the company’s funding profile, balancing immediate cash needs with future dilution through convertibles. We’ll now examine how this sizeable mix of equity and convertible debt financing influences Zenas BioPharma’s investment...
NYSE:TUYA
NYSE:TUYASoftware

Assessing Tuya (TUYA) Valuation After TuyaClaw AI Agent Launch

Tuya (NYSE:TUYA) is back in focus after the company officially launched TuyaClaw, an AI agent built on the OpenClaw architecture that links digital services with physical devices across its smart home ecosystem. See our latest analysis for Tuya. The TuyaClaw launch comes after a mixed run for the stock, with a 9.5% 90 day share price return and a 1 year total shareholder return decline of 18.8%. Recent momentum therefore appears tentative rather than strong. If TuyaClaw has you thinking about...
NYSE:FDS
NYSE:FDSCapital Markets

FactSet (FDS) Q2 EPS Softness Tests Bullish Margin Expansion Narrative

FactSet Research Systems (FDS) has just posted Q2 2026 results with revenue of US$611.0 million and basic EPS of US$3.60, as investors weigh these figures against ongoing earnings expectations. The company has seen quarterly revenue move from US$570.7 million in Q2 2025 to US$611.0 million in Q2 2026, while basic EPS over the same quarters shifted from US$3.81 to US$3.60, presenting a picture of higher top line with changing earnings per share. With a trailing net profit margin of 24.5% and...
NasdaqGS:UFPI
NasdaqGS:UFPIBuilding

A Look At UFP Industries (UFPI) Valuation After New Pneumatic Free Crate Systems Launch

New pneumatic free crate systems spotlight UFP Industries stock UFP Industries (UFPI) drew fresh investor attention after UFP Packaging launched its Slot-Lock and Clamp-Lock 100 crate systems, expanding a pneumatic free lineup focused on workplace safety, reuse, and lower packaging waste. See our latest analysis for UFP Industries. At a share price of $92.12, UFP Industries has seen a 2.38% 1 day share price return and a 1.18% 90 day share price return. Its 1 year total shareholder return of...
NasdaqGS:IBRX
NasdaqGS:IBRXBiotechs

Is It Too Late To Consider ImmunityBio (IBRX) After This Year’s Share Price Surge?

This article examines whether ImmunityBio at US$7.65 still offers value or if most of the opportunity is already reflected in the price, by breaking down what the current market level may be implying. The stock has had a mixed run, with a 3.2% return over the last 7 days, a 21.8% decline over 30 days, a 278.7% return year to date and 158.4% over the past year, while the 5 year return sits at a 59.3% decline and the 3 year return is 355.4%. Recent coverage has focused on ImmunityBio's...
NasdaqGS:XRAY
NasdaqGS:XRAYMedical Equipment

How Investors May Respond To DENTSPLY SIRONA (XRAY) Revenue Contraction And Persistently Negative Returns

DENTSPLY SIRONA recently reported softer quarterly results, with average constant-currency revenue falling 5.5% year-on-year over the past two years and return on invested capital remaining negative. This combination of shrinking revenues and declining returns on invested capital highlights operational challenges that may be linked to intensifying competition or market saturation in key categories. We’ll now examine how DENTSPLY SIRONA’s continued revenue declines and weakening returns could...
NYSE:MD
NYSE:MDHealthcare

Did Pediatrix’s Earnings-Accretive Tennessee MFM Deal Just Shift Pediatrix Medical Group’s (MD) Investment Narrative?

In late March 2026, Pediatrix Medical Group, Inc. expanded its presence in Middle Tennessee by acquiring Tennessee Maternal-Fetal Medicine in a cash deal, integrating five Greater Nashville locations and a ten-provider team under the Maternal-Fetal Medicine Specialists of Tennessee banner, with the transaction expected to be immediately accretive to earnings. This move reinforces Pediatrix’s focus on high-acuity maternal-fetal care and broader regional coverage, potentially enhancing its...
NYSE:BAX
NYSE:BAXMedical Equipment

Baxter’s IV Verify Launch Tests Medication Safety Strategy And Hospital Traction

Baxter International (NYSE:BAX) has introduced the IV Verify Line Labeling System, an automated IV line labeling solution. The system is developed in an exclusive partnership with Vigilant Software to support medication safety and nurse workflow automation. The launch targets long running challenges around inconsistent IV labeling and related medication errors in clinical settings. Baxter International is putting fresh focus on clinician centric products, with IV Verify arriving as a...
NYSE:SE
NYSE:SEMultiline Retail

Sea (NYSE:SE) Valuation Check After Recent Share Price Weakness and Mixed Signals

Sea (NYSE:SE) has drawn investor attention after recent trading left the share price at US$82.81, with returns over the past month and past 3 months showing double digit declines from earlier levels. See our latest analysis for Sea. That 1-day share price return of 5.75% comes after a 30-day share price decline of 23.64% and a year-to-date share price loss of 37.02%. The 1-year total shareholder return is down 37.48%, suggesting recent momentum is still fading despite the latest bounce. If...
NasdaqGS:TER
NasdaqGS:TERSemiconductor

Is It Too Late To Consider Teradyne (TER) After A 260% One Year Surge?

Wondering whether Teradyne at around US$296 a share still makes sense for your portfolio, or if the story is already priced in? The stock has seen a 42.8% return year to date and a 260.2% return over the last year, even with a 7.4% pullback over both the past week and past month. Recent market attention has focused on Teradyne as part of wider interest in semiconductor and automation related names, where expectations and sentiment can shift quickly. News around sector demand, capital...
NasdaqGM:AIRO
NasdaqGM:AIROAerospace & Defense

AIRO Group Holdings (AIRO) Nears Breakeven As Q4 Loss Narrows To US$0.04m

AIRO Group Holdings (AIRO) has just wrapped up FY 2025 with fourth quarter revenue of about US$48.3 million, a small net loss of roughly US$0.04 million and basic EPS close to flat at US$0.00. Trailing twelve month revenue came in at about US$90.9 million with a net loss of around US$4.1 million and basic EPS of a US$0.17 loss. Over recent periods the company has reported quarterly revenue of US$23.7 million in Q4 2024, US$11.8 million in Q1 2025, US$24.6 million in Q2, US$6.3 million in Q3...